Latest Stock Market News

Nykaa shares rose 5.4% to Rs 215.95 after brokerages reaffirmed bullish views post-Q1 results. Net profit jumped 79% YoY to Rs 24 crore, revenue grew 23% to Rs 2,155 crore, and GMV climbed 26% to Rs 4,182 crore. Nuvama and JM Financial maintained Buy ratings, citing strong beauty growth, improving fashion performance, and margin expansion potential.

BlueStone plans to raise up to Rs 1,541 crore via its IPO, comprising a fresh equity issue of Rs 820 crore and an OFS of 1.39 crore shares by existing investors, including Accel India III, Saama Capital II, Kalaari Capital, Iron Pillar, and Sunil Kant Munjal.

Trump threatens legal action against Fed Chair Jerome Powell, slamming rate policy and $3.1B HQ renovation claims.

Andrew Ferris of Ecognosis Advisory suggests that inflation is rising. He believes the Federal Reserve will not cut interest rates in September. He finds the S&P 500 overvalued. Ferris highlights that Indian, South Korean, and Taiwanese markets are performing well. He also notes the strength of defence stocks due to ongoing global conflicts.

Regaal Resources initial public offering of Rs 306 crore witnessed strong investor demand. The IPO was subscribed 7.17 times on its second day. The grey market indicates a premium of 25% over the issue price. The IPO includes a fresh issue and an offer for sale. Proceeds will be used for debt repayment and corporate purposes.

RVNL shares fell after its Q1 profit dropped 40% year-on-year to Rs 134.36 crore, hit by lower revenue and weaker operations. The stock, down 24% in 2025, trades below key SMAs with RSI in oversold territory, signalling continued bearish momentum.

Vikram Solar IPO: Vikram Solar has set a price band of ₹315–₹322 for its ₹2,079.36 crore IPO opening on August 19, comprising a ₹1,500 crore fresh issue and ₹579.36 crore OFS. Minimum bid is 45 shares. The IPO is priced at a P/E of 68.48–72.17x FY25 EPS, higher than the peer average of 44.28x.

Apollo Hospitals Enterprise shares experienced a surge. This followed the company s strong Q1FY26 performance. The healthcare giant reported a significant increase in consolidated net profit. Revenue from operations also grew year-on-year. Positive earnings and revenue growth across business segments boosted investor confidence. The stock is exhibiting a bullish trend, trading above key Simple Moving Averages.

Siddharth Vora advises a large- and midcap bias in choppy markets, favouring domestic-focused sectors like consumption, industrials, materials, and healthcare, while keeping 14–15% cash for opportunities.

India s stock market sentiment has sharply declined, shifting from being the most favored in Asia to the least preferred due to President Trump s tariff escalations. Fund managers are now underweight on Indian equities, influenced by trade tensions, weak earnings, and high valuations. This shift contrasts with increased enthusiasm for Chinese markets, leading to significant fund outflows from Indian shares.